Tick (check) box to add article to PDF "basket"
Bacterial meningitis is a potential constant threat to infant health. The agents most often responsible for the condition are common in the environment. The rapid onset of symptoms can include fever, irritability, rashes, stiffness and vomiting.
Published: 4 June 2014
Published: 27 May 2014
Stroke is the most common neurological disease. It is also the most common cause of life-long impairment in adulthood and of institutionalisation, implying a change from a self-determined, independent life to extensive or complete dependence on others.
Published: 27 May 2014
Today, some 24 million people worldwide are affected by dementia with more than 4 million new cases recorded every year. This equates to a new case every eight seconds. To address these staggering figures, EU-funded researchers have engineered tiny particles to trace and treat Alzheimer's - the most prevalent neurodegenerative disease.
Published: 14 March 2014
Tuberculosis still turns some peoples lives to hell. At a pharmaceutical lab near a hospital in Spain, scientists from a European Union research project are trying to find answers to the complex and often dramatic challenges posed by the disease.
Published: 31 January 2014
Malaria is still a big killer in southern Africa, and all available technologies need to be employed effectively to control the mosquitoes that spread it. Earth Observation (EO) techniques, such as remote aircraft and satellite sensing, can be employed to monitor and manage these malaria vectors.
Published: 29 January 2014
The insulin-producing cells in the pancreas play a crucial role in the management of our blood sugar levels. If they don’t work properly, the body can no longer cope with glucose.
Published: 21 January 2014
Advances in microarray or lab-on-a-chip technologies have significantly improved our ability to study human cells and tissues. However, in order to develop novel therapies to combat such diseases as cancer, understanding the underlying molecular mechanisms is required and this is only made possible by developing new technologies.
Published: 19 December 2012
It is high on the list of every expectant parent's anxieties. Of every 100 newborn babies, one is born with a congenital heart defect. Of these, half will need open-heart surgery to replace a heart valve. It is a traumatic and life-threatening operation.
Published: 31 August 2012
In order to reduce development time for new effective drugs, and thus improve the quality of life and reduce the social costs of disease, it is necessary to identify markers of disease or biological parameters that allow accurate and early diagnosis of the disease and its progression. According to the latest estimates of EU, the cost of brain diseases in Europe in 2004 was of €386 billion and the global prevalence of Alzheimer's disease is predicted to quadruple to 106 million by 2050. The neuGRID e-Infrastructure can process the world's largest Alzheimer's disease imaging database in ten days, instead of five years. That equates to approximately 6,500 brain MRI scans consisting of over 1.6 million images related to more than 700 patients with Alzheimer's disease and Mild Cognitive impairment. This is tremendously effective because the analysis that can be done today in neuGRID would require more than five years to be run on a single computer.
Published: 5 September 2011